Emerald Mutual Fund Advisers Trust Clovis Oncology, Inc. Transaction History

Emerald Mutual Fund Advisers Trust

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Oct 31, 2018	BUY	$29.37 - $49.48 $968,064 - $1.63 Million	32,961 Added 11.3%	324,650 $9.54 Million
Q2 2018 Jul 31, 2018	BUY	$42.06 - $62.4 $5.65 Million - $8.38 Million	134,274 Added 85.3%	291,689 $13.3 Million
Q1 2018 Apr 26, 2018	SELL	$50.12 - $67.72 $2.09 Million - $2.83 Million	-41,723 Reduced 20.95%	157,415 $8.31 Million
Q4 2017 Feb 06, 2018	SELL	$57.69 - $84.58 $4.25 Million - $6.23 Million	-73,675 Reduced 27.01%	199,138 $13.5 Million
Q3 2017 Oct 30, 2017	BUY	$67.17 - $84.81 $18.3 Million - $23.1 Million	272,813	272,813 $22.5 Million

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Emerald Mutual Fund Advisers Trust, based on Form 13F filings with the SEC.

Stay updated on Emerald Mutual Fund Advisers Trust with notifications on news.